Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medinet Co., Ltd. (2370:JPX), powered by AI.
Medinet Co., Ltd. is currently trading at ¥26. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medinet Co., Ltd. on Alpha Lenz.
View Medinet Co., Ltd.'s valuation metrics on Alpha Lenz.
“Medinet Co., Ltd.'s ROE is -30.4%. Explore profitability and growth together.”
Ask for details →Medinet Co., Ltd. is a biomedical research and development company focused on advancing healthcare solutions through innovative biotechnological approaches. The company's primary purpose is to develop, manufacture, and market a wide array of medical and health-related products with an emphasis on cutting-edge therapies and diagnostic tools. Medinet Co., Ltd. plays a pivotal role in the pharmaceuticals, biotechnology, and therapeutics sectors, primarily targeting regenerative medicine and cell therapy technologies. With a commitment to improving patient outcomes, Medinet collaborates with healthcare professionals and institutes to pioneer novel treatments that address critical unmet medical needs. The company’s comprehensive research and development initiatives are designed to facilitate the development of preclinical programs and clinical trials, underscoring its significance in the life sciences industry. Headquartered in Japan, Medinet Co., Ltd. is strategically positioned in the Asian market yet continually seeks alliances that extend its reach and influence in global markets. The company's contributions to the healthcare industry make it a key player in the ongoing pursuit of medical and health innovation.
“Medinet Co., Ltd.'s ROE is -30.4%. Explore profitability and growth together.”
Ask for details →Medinet Co., Ltd. (ticker: 2370) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 92 employees.
The current price is 26 with a P/E ratio of -x and P/B of -x.
ROE is -30.38% and operating margin is -178.39%. Annual revenue is $810M.